pyronaridine has been researched along with Disease Models, Animal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Avery, VM; Baragaña, B; Campbell, SF; Delves, MJ; Duffy, S; Fairlamb, AH; Frearson, JA; Gilbert, IH; Gray, DW; Grimaldi, R; Hallyburton, I; Meister, S; Norcross, NR; Norval, S; Osuna-Cabello, M; Porzelle, A; Read, KD; Riley, J; Simeons, FR; Sinden, RE; Stojanovski, L; Waterson, D; Willis, P; Wilson, C; Winzeler, EA; Wittlin, S; Wyatt, PG | 1 |
| Avery, VM; Baell, JB; Bullen, HE; Cowman, AF; Crabb, BS; Curtis, JM; Di Rago, AE; Duffy, S; Gilson, PR; Hutton, CA; Jarman, KE; Jousset Subroux, H; Lowes, KN; Nguyen, W; Prinz, B; Sleebs, BE; Tan, C | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Anantpadma, M; Comer, JE; Davey, RA; Dyall, J; Ekins, S; Freiberg, AN; Holbrook, MR; Lane, TR; Madrid, PB; Massey, C; Zhou, H | 1 |
| Byamukama, B; El-Sayed, SAE; Igarashi, I; Ji, S; Li, J; Li, Y; Liu, M; Ringo, AE; Rizk, MA; Tumwebaze, MA; Xuan, X | 1 |
| Cai, Y; Chollet, J; Tanner, M; Utzinger, J; Xiao, SH; Yao, JM | 1 |
| Chen, YD; Lin, BY; Pan, YR; Tang, WZ; Xu, B; Zhang, JX; Zheng, H | 1 |
| Fang, Y; Lin, BY; Pan, YR; Zhang, JX; Zheng, H | 2 |
9 other study(ies) available for pyronaridine and Disease Models, Animal
| Article | Year |
|---|---|
Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy.
Topics: Animals; Antimalarials; Disease Models, Animal; Drug Discovery; Malaria; Mice; Molecular Structure; Plasmodium falciparum; Quinolines; Structure-Activity Relationship | 2016 |
Optimization of 2-Anilino 4-Amino Substituted Quinazolines into Potent Antimalarial Agents with Oral in Vivo Activity.
Topics: Administration, Oral; Animals; Antimalarials; Disease Models, Animal; Mice; Plasmodium falciparum; Quinazolines; Structure-Activity Relationship | 2017 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Pyronaridine tetraphosphate efficacy against Ebola virus infection in guinea pig.
Topics: Animals; Antiviral Agents; Disease Models, Animal; Drug Repositioning; Ebolavirus; Female; Guinea Pigs; Hemorrhagic Fever, Ebola; Humans; Inhibitory Concentration 50; Male; Marburgvirus; Mice; Microsomes; Naphthyridines | 2020 |
Impact of using pyronaridine tetraphosphate- based combination therapy in the treatment of babesiosis caused by Babesia bovis, B. caballi, and B. gibsoni in vitro and B. microti in mice.
Topics: Animals; Antiprotozoal Agents; Babesia; Babesiosis; Disease Models, Animal; Female; Mice; Mice, Inbred BALB C; Naphthyridines | 2021 |
Selection and reversal of Plasmodium berghei resistance in the mouse model following repeated high doses of artemether.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Disease Models, Animal; Drug Resistance; Female; Immunity, Innate; Malaria; Male; Mice; Mice, Inbred Strains; Naphthyridines; Plasmodium berghei; Sesquiterpenes | 2004 |
[Studies on the establishment of malarial animal model of short-term relapse. IV. Short-term relapse in rhesus monkeys infected with sporozoites of Plasmodium cynomolgi].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Disease Models, Animal; Drug Therapy, Combination; Erythrocytes; Macaca mulatta; Malaria; Naphthyridines; Plasmodium cynomolgi; Recurrence; Sesquiterpenes | 1993 |
[Studies on the establishment of malarial animal model of short-term relapse. III. Combined therapy with pyronaridine-artemether-chloroquine for parasitemia clearance].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Disease Models, Animal; Drug Therapy, Combination; Macaca mulatta; Malaria; Naphthyridines; Plasmodium cynomolgi; Recurrence; Sesquiterpenes | 1993 |
[Studies on the establishment of malarial animal model of short-term relapse. II. The phenomenon of sustained special ring form parasitemia in Plasmodium cynomolgi infection].
Topics: Aminoquinolines; Animals; Antimalarials; Disease Models, Animal; Macaca mulatta; Malaria; Naphthyridines; Plasmodium cynomolgi; Recurrence | 1992 |